首页> 外文期刊>妇产科期刊(英文) >Study of Prevalence of Abnormal Cervical Cytology in Al-Shatby Maternity University Hospital
【24h】

Study of Prevalence of Abnormal Cervical Cytology in Al-Shatby Maternity University Hospital

机译:基于初学大学医院异常宫颈细胞学患病率研究

获取原文
获取原文并翻译 | 示例
       

摘要

Introduction: Cervical cancer is the most common cause of preventable cancer related deaths;cervical cancer has a long pervasive phase (cervical dysplasia);the prevalence of cervical dysplasia varies according to the socioeconomic characteristics and geographic areas of the population studied. Low-grade lesions regress spontaneously in a significant number of patients, while high grade lesions will progress to an invasive cancer if left untreated. Cervical cancer screening is an important component of the World Health Organization (WHO) strategy for combating cervical cancer. The incidence and prevalence of cervical cancer has reduced remarkably over the last three decades in developed countries where there are effective, well-coordinated screening programs, and treatment of cervical dysplasia, while in developing countries it has been increasing and has constituted major health problems among women where there are no well-coordinated and effective screening programs, also resources are very low and no insurance can cover this programs. Aim of the work: The aim is to assess the prevalence of abnormal cervical cytology in Al Shatby Maternity University Hospital patients using Pap smear. Materials and methods: Inclusion criteria: 1) Married woman from 3 years or more;2) Women age from 21 to age 65 years. Exclusion criteria: 1) Previously known cervical cancer patient;2) Virgin females;3) Woman with active vaginal bleeding. Results: 83% of patients were -ve intraepithelial neoplasia {37.7% was normal cytology and 45.3% was inflammatory}. 17% was +ve intraepithelial neoplasia (abnormal cytology), {11.1% ASCUS, 2.9% LSIL, 1.3% HSIL, 1.1% ASC-H, 0.3% AGS-NO, 0.3% AGS-Favour Neoplastic}. Prevalence of abnormal cervical cytology in age group less than30 years was 8.4% which is lower than prevalence in the middle age group which was 19.9%. Prevalence of abnormal cervical cytology in women with normal vaginal delivery was higher than those with caesarean delivery. 39.8% of our patients were passive and active smokers 61.2% of their Pap smear was abnormal cytology. 78.9% of abnormal cytology was among patients from low socioeconomic class (rural style="font-family:Verdana;">areas). Abnormal cervical cytology in patients with high parity was 69% which style="font-family:Verdana;"> is higher than abnormality found in lower parity. 60.2% of abnormal cervical cytology was in patients who became sexually active before age of 20 years. Prevalence of abnormal cervical cytology was higher in patients with multiple sexual partners (56.5%) than patients with single sexual partner (13.3%). Conclusion: Cervical cytology remains the gold standard for cervical cancer screening and the use of Bethesda system is a simple and accurate method for diagnosis and management of cases with abnormal cervical cytology.
机译:介绍:宫颈癌是可预防癌症相关死亡的最常见原因;宫颈癌具有长普遍性的阶段(宫颈发育不良);宫颈发育不良的患病率根据学习的人口的社会经济特征和地理区域而异。低级病变在大量患者中自发地归因,而高级病变会在未经处理的情况下进入侵入性癌症。宫颈癌筛查是世界卫生组织(WHO)抗击宫颈癌的战略的重要组成部分。在发达国家的过去三十年中,宫颈癌的发病率和患病率显着减少了有效,协调的筛查计划,以及宫颈发育不良的治疗,而在发展中国家的情况下,它一直在增加,并在造成的主要健康问题没有良好协调和有效的筛查计划的女性,资源也很低,没有保险可以涵盖这个计划。作品的目的:目的是评估使用PAP涂片的Al Shatby妇产病患者异常宫颈细胞学的患病率。材料和方法:纳入标准:1)已婚妇女从3年或更长时间; 2)女性年龄从21岁到65岁。排除标准:1)以前已知的宫颈癌患者; 2)处女女性; 3)活跃阴道出血的女人。结果:83%的患者 - 术中前进的肿瘤{37.7%是正常细胞学,45.3%是炎症}。 17%是+ ve含有术前皮瘤形成(异常细胞学),{11.1%ASCUS,2.9%LSIL,1.3%HSIL,1.1%ASC-H,0.3%AGS-NO,0.3%AGS-WAL,优选肿瘤}。年龄组宫颈细胞学的患病率少于30岁的时间为8.4%,其中年组的患病率低19.9%。阴道分娩正常递送的女性异常宫颈细胞学的患病率高于伴随剖腹产。 39.8%的患者是被动,活性吸烟者61.2%的PAP涂片是异常的细胞学。 78.9%的异常细胞学是来自低社会经济阶级的患者(农村 <跨度风格=“字体家族:Verdana;”>区域)。高奇偶校验患者的异常宫颈细胞学为69%,其中 <跨度样式=“字体家族:Verdana;”>高于较低奇偶校验中发现的异常。 60.2%的异常宫颈细胞学是在20年龄之前发生性活跃的患者。多种性伴侣(56.5%)的患者异常宫颈细胞学的患病率高于单一性伴侣(13.3%)。结论:宫颈细胞学仍然是宫颈癌筛查的黄金标准,贝塞斯达系统的使用是一种简单准确的宫颈细胞学病例的诊断和管理方法。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号